Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Indeterminate adrenal masses (AM) pose a diagnostic challenge, and 2-[F]FDG PET-CT serves as a problem-solving tool. Aim of this study was to investigate whether CT radiomics features could be used to predict the 2-[F]FDG SUVmax of AM.
Methods: Patients with AM on 2-[F]FDG PET-CT scan were grouped based on iodine contrast injection as CT contrast-enhanced (CE) or CT unenhanced (NCE). Two-dimensional segmentations of AM were manually obtained by multiple operators on CT images. Image resampling and discretization (bin number = 16) were performed. 919 features were calculated using PyRadiomics. After scaling, unstable, redundant, and low variance features were discarded. Using linear regression and the Uniform Manifold Approximation and Projection technique, a CT radiomics synthetic value (RadSV) was obtained. The correlation between CT RadSV and 2-[F]FDG SUVmax was assessed with Pearson test.
Results: A total of 725 patients underwent PET-CT from April 2020 to April 2021. In 150 (21%) patients, a total of 179 AM (29 bilateral) were detected. Group CE consisted of 84 patients with 108 AM (size = 18.1 ± 4.9 mm) and Group NCE of 66 patients with 71 AM (size = 18.5 ± 3.8 mm). In both groups, 39 features were selected. No statisticallyf significant correlation between CT RadSV and 2-[F]FDG SUVmax was found (Group CE, = 0.18 and = 0.058; Group NCE, = 0.13 and = 0.27).
Conclusions: It might not be feasible to predict 2-[F]FDG SUVmax of AM using CT RadSV. Its role as a problem-solving tool for indeterminate AM remains fundamental.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340369 | PMC |
| http://dx.doi.org/10.3390/cancers15133439 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
Am J Cardiol
October 2023
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota. Electronic address:
Article Synopsis
- The study investigates the effects of TNF-α inhibitors, infliximab and adalimumab, on patients with cardiac sarcoidosis (CS), analyzing their disease progression through imaging and clinical outcomes.
- A total of 31 patients were observed, showing a significant reduction in their average prednisone dose and a notable decrease in the number of heart segments with elevated FDG uptake after treatment.
- Results suggest that TNF-α inhibitor therapy in CS patients leads to lower steroid use and minimal cardiac issues, although some patients experienced unplanned hospitalizations.
Specific features to differentiate Giant cell arteritis aortitis from aortic atheroma using FDG-PET/CT.
Sci Rep
August 2021
Department of Nuclear Medicine, CHU de Nantes, 44000, Nantes, France.
Aortic wall F-fluorodeoxyglucose (FDG)-uptake does not allow differentiation of aortitis from atheroma, which is problematic in clinical practice for diagnosing large vessel vasculitis giant-cell arteritis (GCA) in elderly patients. The purpose of this study was to compare the FDG uptake characteristics of GCA aortitis and aortic atheroma using positron emission tomography/FDG computed tomography (FDG-PET/CT). This study compared FDG aortic uptake between patients with GCA aortitis and patients with aortic atheroma; previously defined by contrast enhanced CT.
View Article and Find Full Text PDFTargeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [F]FDG PET/CT and MRI.
Eur J Nucl Med Mol Imaging
November 2021
Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Josef-Schneider-Str. 6, 97080, Würzburg, Germany.
Purpose: While [F]-fluorodeoxyglucose ([F]FDG) is the standard for positron emission tomography/computed tomography (PET/CT) imaging of oral squamous cell carcinoma (OSCC), diagnostic specificity is hampered by uptake in inflammatory cells such as neutrophils or macrophages. Recently, molecular imaging probes targeting fibroblast activation protein α (FAP), which is overexpressed in a variety of cancer-associated fibroblasts, have become available and might constitute a feasible alternative to FDG PET/CT.
Methods: Ten consecutive, treatment-naïve patients (8 males, 2 females; mean age, 62 ± 9 years) with biopsy-proven OSCC underwent both whole-body [F]FDG and [Ga]FAPI-04 (FAP-directed) PET/CT for primary staging prior to tumor resection and cervical lymph node dissection.
[Simultaneous Laparoscopic Sigmoid Colectomy and Malignant Lymphoma Biopsy-A Case Report].
Gan To Kagaku Ryoho
March 2019
Dept. of Surgery, National Hospital Organization Osaka National Hospital.
The patient, a woman in her 70s, was diagnosed with occlusive ileus caused by sigmoid colon cancer.She underwent transanal stent placement to release the occlusion.Subsequent detailed testing revealed a 70×60mm mass on the dorsal side of the pancreas and PET-CT indicated an SUVmax 18.
View Article and Find Full Text PDFAccurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma.
Cancer Imaging
September 2018
Department of Nuclear Medicine, Busan Seongso Hospital, Suyeong-ro, Nam-gu, Busan, 48453, Republic of Korea.
Background: In a previous study, FDG PET tumor segmentation (SegPHL) using the peritumoral halo layer (PHL) was more reliable than fixed threshold methods in patients with thyroid cancer. We performed this study to validate the reliability and accuracy of the PHL method in patients with esophageal squamous cell carcinomas (ESCCs), which can be larger and more heterogeneous than thyroid cancers.
Methods: A total of 121 ESCC patients (FDG avid = 85 (70.